| Literature DB >> 26750673 |
Rabie Soliman1, Eman Fouad, Makhlouf Belghith, Tarek Abdelmageed.
Abstract
OBJECTIVE: To evaluate the effect of hemofiltration during cardiopulmonary bypass on lactate level in adult patients who underwent cardiac surgery.Entities:
Mesh:
Substances:
Year: 2016 PMID: 26750673 PMCID: PMC4900403 DOI: 10.4103/0971-9784.173019
Source DB: PubMed Journal: Ann Card Anaesth ISSN: 0971-9784
Figure 1Consort flow diagram of adult patients undergoing cardiac surgery and participating in the study
Preoperative data of patients
| Items | Group H ( | Group C ( | |
|---|---|---|---|
| Age (year) | 59.66±11.57 | 59.75±12.10 | 0.949 |
| Weight (kg) | 81.60±7.12 | 80.37±6.67 | 0.812 |
| Gender (female:male) | 73:72 | 77:61 | 0.358 |
| DM (number of patients) | 83 | 91 | 0.651 |
| Hypertension (number of patients) | 102 | 98 | 0.242 |
| IHD (number of patients) | 108 | 105 | 0.547 |
| Ejection fraction (%) | 55.35±16.40 | 56.51±15.88 | 0.145 |
| Euroscore | 12.31±2.41 | 12.00±2.52 | 0.557 |
Data are presented as mean±SD, n (%). DM: Diabetes mellitus, IHD: Ischemic heart disease, SD: Standard deviation
Intraoperative data of patients
| Items | Group H ( | Group C ( | |
|---|---|---|---|
| Heart rate (bpm) | 80.17±7.20 | 80.37±6.78 | 0.151 |
| MAP (mmHg) | 93.02±6.12 | 92.77±7.15 | 0.751 |
| CVP (mmHg) | 12.68±1.76 | 12.50±1.83 | 0.399 |
| SPO2 (%) | 99.30±0.80 | 99.27±0.65 | 0.730 |
| Temperature (°C) | 36.76±0.11 | 36.72±0.33 | 0.102 |
| CABG (number of patients) | 73 | 68 | 0.857 |
| CABG + valvular surgery (number of patients) | 35 | 39 | 0.430 |
| Valvular surgery (number of patients) | 37 | 31 | 0.547 |
| CPB time (min) | 115.34±17.21 | 114.32±17.63 | 0.625 |
| Cross clamping (min) | 99.36±13.79 | 99.31±13.30 | 0.971 |
| Duration of cooling (min) | 79.40±11.78 | 77.16±9.35 | 0.850 |
| Duration of rewarming (min) | 25.55±4.10 | 26:00±4.01 | 0.961 |
| Dopamine | |||
| Number of patients | 96 | 123 | 0.001 |
| Dose (μg/kg/min) | 5.23±1.63 | 7.95±197 | 0.001 |
| Epinephrine | |||
| Number of patients | 42 | 40 | 0.001 |
| Dose (μg/kg/min) | 0.08±0.02 | 0.12±0.05 | 0.001 |
| Norepinephrine | |||
| Number of patients | 16 | 33 | 0.001 |
| Dose (μg/kg/min) | 0.03±0.02 | 0.05±0.03 | 0.008 |
| IABP (number of patients) | 17 | 38 | 0.015 |
| Packed red blood cells (units) | 1.55±0.28 | 2.78±0.78 | 0.005 |
| Urine (L) | 1.49±0.28 | 3.62±0.46 | 0.001 |
| Fluid removal (L) | 2.56±0.22 | - | 0.001 |
Data are presented as mean±SD, number. MAP: Mean arterial blood pressure, SPO2: Arterial oxygen saturation, CVP: Central venous pressure, CABG: Coronary artery bypass grafting, IABP: Intra-aortic balloon pump, CPB: Cardiopulmonary bypass, SD: Standard deviation
Laboratory data of patients
| Items | T0 | T1 | T2 | T3 | T4 | T5 | T6 |
|---|---|---|---|---|---|---|---|
| Lactate level (mmol/L) | |||||||
| Group H | 1.17±0.49 | 3.05±0.60 | 5.07±1.00 | 6.31±1.20 | 7.33±1.05 | 5.33±1.25 | 2.10±0.90 |
| Group C | 1.09±0.51 | 2.87±0.36 | 3.03±0.65 | 3.20±0.80 | 2.28±0.62 | 2.10±1.15 | 1.92±0.73 |
| | 0.251 | 0.003 | 0.003 | 0.001 | 0.001 | 0.004 | 0.060 |
| VO2 (%) | |||||||
| Group H | 70.78±2.26 | 60.07±5.30 | 51.83±5.15 | 56.42±4.31 | 61.55±4.39 | 66.44±3.73 | 72.23±2.94 |
| Group C | 71.00±3.44 | 63.00±4.75 | 58.50±4.43 | 61.30±5.59 | 67.43±4.50 | 69.70±2.25 | 71.84±2.70 |
| | 0.07 | 0.001 | 0.001 | 0.001 | 0.001 | 0001 | 0.245 |
| Blood sugar (mmol/L) | |||||||
| Group H | 7.90±0.70 | 8.42±1.19 | 8.15±0.83 | 8.40±1.98 | 8.20±1.65 | 8.73±1,30 | 8.45±1.40 |
| Group C | 8.19±1.24 | 8.24±1.37 | 7.93±1.86 | 7.99±1.59 | 8.12±1.50 | 8.23±1.50 | 8.31±1.61 |
| | 0.127 | 0.225 | 0.312 | 0.055 | 0.669 | 0.267 | 0.436 |
| pH | |||||||
| Group H | 7.37±0.02 | 7.30±0.03 | 7.31±0.03 | 7.30±0.04 | 7.31±0.03 | 7.33±0.04 | 7.36±0.02 |
| Group C | 7.38±0.02 | 7.36±0.02 | 7.36±0.01 | 7.34±0.03 | 7.36±0.03 | 7.37±0.03 | 7.36±0.04 |
| | 0.168 | 0.023 | 0.031 | 0.021 | 0.025 | 0.041 | 1.000 |
| PaCO2 (mmHg) | |||||||
| Group H | 35.62±1.51 | 35.35±1.74 | 34.64±1.51 | 35.12±1.35 | 35.50±1.21 | 36.40±1.10 | 35.76±1.42 |
| Group C | 35.36±2.31 | 35.03±1.58 | 34.23±1.68 | 34.84±1.60 | 35.33±1.34 | 36.74±1.35 | 35.54±1.51 |
| | 0.263 | 0.259 | 0.116 | 0.113 | 0.264 | 0.237 | 0.208 |
| Hematocrit value (%) | |||||||
| Group H | 38.69±3.04 | 29.86±3.25 | 31.57±2.62 | 32.43±2.33 | 33.25±2.50 | 34.62±2.40 | 35.29±2.32 |
| Group C | 39.30±3.20 | 26.42±2.73 | 31.88±2.74 | 31.98±2.67 | 32.87±2.81 | 33.81±2.73 | 35.44±2.45 |
| | 0.104 | 0.003 | 0.334 | 0.133 | 0.231 | 0.263 | 0.597 |
Data are presented as mean±SD, percentage. Group H: Hemofiltration group, Group C: Control group, T0: Values before cardiopulmonary bypass, T1: Values before weaning of cardiopulmonary bypass, T2: Values after cardiopulmonary bypass, T3: Values on ICU admission, T4: Values 6 hours after ICU admission, T5: Values 12 h after ICU admission, T6: Values 24 h after ICU admission, VO2: Central venous oxygen saturation, PaCO2: Arterial partial pressure of carbon dioxide, SD: Standard deviation